349 related articles for article (PubMed ID: 27163826)
1. Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
Farnsworth B; Peuckert C; Zimmermann B; Jazin E; Kettunen P; Emilsson LS
J Alzheimers Dis; 2016 May; 53(1):209-19. PubMed ID: 27163826
[TBL] [Abstract][Full Text] [Related]
2. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.
Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B
Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
4. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
5. PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach.
Delabio R; Rasmussen L; Mizumoto I; Viani GA; Chen E; Villares J; Costa IB; Turecki G; Linde SA; Smith MC; Payão SL
J Alzheimers Dis; 2014; 42(3):757-60. PubMed ID: 24927704
[TBL] [Abstract][Full Text] [Related]
6. Gene mutations in a Han Chinese Alzheimer's disease cohort.
Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
[TBL] [Abstract][Full Text] [Related]
7. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
8. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
9. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
[TBL] [Abstract][Full Text] [Related]
10. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.
Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Al-Sarraj S; Niblock M; Gallo JM; Adnan J; Killick R; Brown KS; Medway C; Lord J; Turton J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
Neurobiol Aging; 2014 Dec; 35(12):2881.e1-2881.e6. PubMed ID: 25104557
[TBL] [Abstract][Full Text] [Related]
11. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
12. The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes.
Sharman MJ; Moussavi Nik SH; Chen MM; Ong D; Wijaya L; Laws SM; Taddei K; Newman M; Lardelli M; Martins RN; Verdile G
PLoS One; 2013; 8(6):e66235. PubMed ID: 23805206
[TBL] [Abstract][Full Text] [Related]
13. Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.
Soler-López M; Zanzoni A; Lluís R; Stelzl U; Aloy P
Genome Res; 2011 Mar; 21(3):364-76. PubMed ID: 21163940
[TBL] [Abstract][Full Text] [Related]
14. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
16. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity.
Moussavi Nik SH; Newman M; Wilson L; Ebrahimie E; Wells S; Musgrave I; Verdile G; Martins RN; Lardelli M
Hum Mol Genet; 2015 Jul; 24(13):3662-78. PubMed ID: 25814654
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.
Galla L; Redolfi N; Pozzan T; Pizzo P; Greotti E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991578
[TBL] [Abstract][Full Text] [Related]
19. Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
Chintapaludi SR; Uyar A; Jackson HM; Acklin CJ; Wang X; Sasner M; Carter GW; Howell GR
J Alzheimers Dis; 2020; 73(4):1421-1434. PubMed ID: 31929156
[TBL] [Abstract][Full Text] [Related]
20. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
